Suppr超能文献

调查40至74岁女性的乳腺筛查钼靶检查参与情况。

Examining screening mammography participation among women aged 40 to 74.

作者信息

Volesky Karena D, Villeneuve Paul J

机构信息

Doctoral student in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University in Montreal, Que.

Associate Professor in the Department of Health Sciences at Carleton University in Ottawa, Ont.

出版信息

Can Fam Physician. 2017 Jun;63(6):e300-e309.

Abstract

OBJECTIVE

To examine participation in screening mammography among women aged 40 to 74 and identify which factors are associated with those women who participate in screening.

DESIGN

Secondary analysis of the cross-sectional 2012 Canadian Community Health Survey.

SETTING

Canada.

PARTICIPANTS

A population-based national sample of 18 312 women aged 40 to 74.

MAIN OUTCOME MEASURES

Women's participation in screening mammography in the 2 years preceding the 2012 Canadian Community Health Survey; women's preventive health activities (ie, having a regular doctor, a recent physical checkup, and a Papanicolaou test), which were adjusted for sociodemographic factors.

RESULTS

Participation in recent screening mammography was highest among women aged 60 to 69 (70.3%), followed by those aged 50 to 59 (63.4%) and those aged 70 to 74 (58.4%). Almost one-third (31.4%) of women aged 40 to 49 had had a screening mammogram in the past 2 years. Having a regular doctor (odds ratio [OR] = 3.30, 95% CI 2.90 to 3.73), a physical checkup in the past year (OR = 3.06, 95% CI 2.30 to 4.08), or a Pap test in the past 3 years (OR = 3.47, 95% CI 3.18 to 3.79) more than tripled the odds that women had had a recent screening mammogram.

CONCLUSION

Aside from age being a factor associated with women's participation in screening mammography, factors related to women's health care use (having a regular doctor, a recent physical checkup, and a recent Pap test) demonstrated a stronger association with women aged 40 to 74 having had recent mammograms. The association between women's participation in screening and their preventive health activities implies that the doctor's office is an appropriate venue for conversations regarding the potential benefits and harms of screening mammography.

摘要

目的

调查40至74岁女性参与乳腺钼靶筛查的情况,并确定哪些因素与参与筛查的女性相关。

设计

对2012年加拿大社区健康调查的横断面数据进行二次分析。

地点

加拿大。

参与者

基于人群的18312名40至74岁女性的全国样本。

主要观察指标

2012年加拿大社区健康调查前两年女性参与乳腺钼靶筛查的情况;女性的预防性健康活动(即有固定医生、近期进行过身体检查和巴氏试验),并对社会人口学因素进行了调整。

结果

60至69岁女性近期参与乳腺钼靶筛查的比例最高(70.3%),其次是50至59岁女性(63.4%)和70至74岁女性(58.4%)。40至49岁女性中近三分之一(31.4%)在过去两年内进行过乳腺钼靶筛查。有固定医生(优势比[OR]=3.30,95%置信区间2.90至3.73)、过去一年进行过身体检查(OR=3.06,95%置信区间2.30至4.08)或过去三年进行过巴氏试验(OR=3.47,95%置信区间3.18至3.79)的女性近期进行乳腺钼靶筛查的几率增加两倍多。

结论

除年龄是与女性参与乳腺钼靶筛查相关的因素外,与女性医疗保健利用相关的因素(有固定医生、近期进行过身体检查和近期进行过巴氏试验)与40至74岁女性近期进行乳腺钼靶检查的关联更强。女性参与筛查与其预防性健康活动之间的关联表明,医生办公室是讨论乳腺钼靶筛查潜在益处和危害的合适场所。

相似文献

引用本文的文献

本文引用的文献

1
Breast-cancer screening--viewpoint of the IARC Working Group.乳腺癌筛查——国际癌症研究机构工作组的观点
N Engl J Med. 2015 Jun 11;372(24):2353-8. doi: 10.1056/NEJMsr1504363. Epub 2015 Jun 3.
2
Priorities for the primary prevention of breast cancer.乳腺癌初级预防的重点。
CA Cancer J Clin. 2014 May-Jun;64(3):186-94. doi: 10.3322/caac.21225. Epub 2014 Mar 19.
4
Mammography screening: truth, lies, and controversy.乳腺钼靶筛查:真相、谎言与争议。
Lancet. 2012 Jul 21;380(9838):218. doi: 10.1016/S0140-6736(12)61216-1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验